CORD-19:0329e0f2e3b8ab0eabe2afe0e5214cc88c61080e / 0-397 JSONTXT

{"project":"CORD-19-Sentences","denotations":[{"id":"TextSentencer_T1","span":{"begin":0,"end":181},"obj":"Sentence"},{"id":"TextSentencer_T2","span":{"begin":183,"end":191},"obj":"Sentence"},{"id":"TextSentencer_T3","span":{"begin":194,"end":309},"obj":"Sentence"},{"id":"T28156","span":{"begin":0,"end":181},"obj":"Sentence"},{"id":"T94036","span":{"begin":183,"end":191},"obj":"Sentence"},{"id":"T33176","span":{"begin":194,"end":309},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Journal Pre-proof Favipiravir, an anti-influenza drug against life-threatening RNA virus infections Favipiravir, an anti-influenza drug against life-threatening RNA virus infections\n\nAbstract\n\n\nAcyclovir enabled the first systemic antiviral therapy, and many antiviral agents have subsequently been developed. Acyclovir targets herpes simplex virus and varicella-zoster infection, and individual a"}

{"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T1","span":{"begin":0,"end":181},"obj":"Sentence"},{"id":"T2","span":{"begin":183,"end":191},"obj":"Sentence"},{"id":"T3","span":{"begin":194,"end":309},"obj":"Sentence"}],"text":"Journal Pre-proof Favipiravir, an anti-influenza drug against life-threatening RNA virus infections Favipiravir, an anti-influenza drug against life-threatening RNA virus infections\n\nAbstract\n\n\nAcyclovir enabled the first systemic antiviral therapy, and many antiviral agents have subsequently been developed. Acyclovir targets herpes simplex virus and varicella-zoster infection, and individual a"}

{"project":"CORD-19-PD-MONDO","denotations":[{"id":"T1","span":{"begin":39,"end":48},"obj":"Disease"},{"id":"T2","span":{"begin":83,"end":99},"obj":"Disease"},{"id":"T3","span":{"begin":121,"end":130},"obj":"Disease"},{"id":"T4","span":{"begin":165,"end":181},"obj":"Disease"},{"id":"T5","span":{"begin":328,"end":342},"obj":"Disease"},{"id":"T6","span":{"begin":353,"end":379},"obj":"Disease"},{"id":"T7","span":{"begin":353,"end":362},"obj":"Disease"},{"id":"T8","span":{"begin":370,"end":379},"obj":"Disease"}],"attributes":[{"id":"A1","pred":"mondo_id","subj":"T1","obj":"http://purl.obolibrary.org/obo/MONDO_0005812"},{"id":"A2","pred":"mondo_id","subj":"T2","obj":"http://purl.obolibrary.org/obo/MONDO_0005108"},{"id":"A3","pred":"mondo_id","subj":"T3","obj":"http://purl.obolibrary.org/obo/MONDO_0005812"},{"id":"A4","pred":"mondo_id","subj":"T4","obj":"http://purl.obolibrary.org/obo/MONDO_0005108"},{"id":"A5","pred":"mondo_id","subj":"T5","obj":"http://purl.obolibrary.org/obo/MONDO_0004609"},{"id":"A6","pred":"mondo_id","subj":"T6","obj":"http://purl.obolibrary.org/obo/MONDO_0005608"},{"id":"A7","pred":"mondo_id","subj":"T7","obj":"http://purl.obolibrary.org/obo/MONDO_0005700"},{"id":"A8","pred":"mondo_id","subj":"T8","obj":"http://purl.obolibrary.org/obo/MONDO_0005550"}],"text":"Journal Pre-proof Favipiravir, an anti-influenza drug against life-threatening RNA virus infections Favipiravir, an anti-influenza drug against life-threatening RNA virus infections\n\nAbstract\n\n\nAcyclovir enabled the first systemic antiviral therapy, and many antiviral agents have subsequently been developed. Acyclovir targets herpes simplex virus and varicella-zoster infection, and individual a"}